Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...

The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel ...

Photo/Agencies] Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in ...

Users of fat-shedding and diabetes jabs are reporting alarming cases of “Ozempic ear”, describing popping and crackling ...

Having been taking a GLP-1, tirzepatide, for about five months, I can share how it impacted me, as the experience is not the ...

NVO and AMGN square off as GLP-1 leadership, pipeline depth and diversification shape a compelling healthcare stock ...

Perhaps even more unsettling were the ads for telehealth company Ro that played throughout the season, specifically ...

Scientists found a key to Ozempic’s rise in Gila monster venom, leading to Byetta and the modern era of GLP-1 diabetes and ...

Brazil's health regulator Anvisa said on Tuesday it had approved ​EMS's Ozivy, the country's first semaglutide-based ‌injector pen, as the drugmaker looks to expand into a higher-end segment of the ...

Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage ...